Kim Wellman

Kim Wellman is a scientist at A-Alpha Bio. Kim has a PHD from the University of Colorado Anschutz Medical Campus, where they studied RNA regulatory networks in human health. Kim has also worked as a research scientist for Adaptive Biotechnologies Corp, where they developed immunosequencing assays and characterized somatic hypermutation in human B-cell populations.

Kim Wellman has a PhD in Molecular Biology from the University of Colorado Anschutz Medical Campus and a BS in Microbiology, General from the University of Washington.